COLLEGE PARK, Md.--(BUSINESS WIRE)--June 14, 2006--Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, today announced that Dr. David H. Gelfand, formerly of Roche Molecular Systems, Inc., will join its Scientific Advisory Board.
